Richtlijn 'Behandeling van astma bij kinderen': 3 controversiële behandelopties

Translated title of the contribution: Guideline "Treatment of asthma in children": 3 controversial approaches to treatment

Bart L Rottier, Hettie M Janssens, Johan C de Jongste, Marianne L Brouwer, Elianne J L E Vrijlandt, Nicole Boluyt

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

In context of the development of evidence-based guidelines by the Dutch Paediatric Society, the three most important controversies in asthma treatment in children were investigated by systematic literature review and assessed based on the quality of evidence according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Although the quality of evidence was low, this method did result in clear, although weak, recommendations, in which the considerations playing a role are made clear. In young children with severe and/or recurrent wheezing, maintenance treatment using an inhalation corticosteroid (ICS) is initially recommended. When inhalation technique is poor, a leukotriene receptor antagonist (LTRA) can be given instead. Inhalation corticosteroids with ultrafine particles are not specifically recommended as first line treatment in young children. If asthma is not controlled despite use of ICS, it is advised to double the dose of ICS after unfavourable environmental factors have been excluded. If the result is insufficient, a combination of ICS and a long acting bronchodilator is prescribed in children older than 4- 6 years of age.

Translated title of the contributionGuideline "Treatment of asthma in children": 3 controversial approaches to treatment
Original languageDutch
Pages (from-to)A4389
JournalNederlands Tijdschrift voor Geneeskunde
Volume156
Issue number23
Publication statusPublished - 2012

Keywords

  • English Abstract
  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Guideline "Treatment of asthma in children": 3 controversial approaches to treatment'. Together they form a unique fingerprint.

Cite this